February 26, 2010
Section : Mental Health Info

Becoming a caregiver is not an easy task for family and friends of a loved one with Alzheimer's Disease.

February 22, 2025
Section : Patient care

The Clinic for Assessment of Youth at Risk (CAYR) is a sub-program of PEPP-Montréal and accepts youth between 14 and 30 years of age who have never experienced a psychotic episode but who show signs of increased risk for developing psychosis.

April 22, 2010
Section : Patient care

Treating psychosis involves education, counselling, medication, close monitoring of symptoms, stress management, and a strong, supportive environment.

April 20, 2010
Section : Patient care

The Anxiety Disorders Clinic is a superspecialized (third-line) consultation, assessment and treatment service for people between the ages of 18 and 65 who suffer from one or multiple anxiety disorders.

April 20, 2010
Section : Patient care

The Mood, Anxiety and Impulsivity Disorders Program at the Douglas Institute provides care to people aged 18 to 65 years with a mood disorder such as Bipolar disorders or Depressive and suicide disorders.

April 23, 2010
Section : The Douglas

Douglas Hospital was founded in 1881 by Alfred Perry and a group of Protestant clergy and Montréal citizens.

February 22, 2025
Section : Mental Health Info

Cognitive remediation is a computer-assisted therapy that promotes the stimulation of cognitive skills necessary for everyday life. Many studies have shown this therapy to have a measurable impact on cognitive deficits related to dementia, making it an invaluable intervention tool in the treatment of Alzheimer's disease.

October 11, 2011
Section : Research

Weiya Ma’s long-term research interest is to advance the understanding of how substances involved in the inflammation process play a role in the development of chronic pain conditions.

February 18, 2011
Section : Research

Fabrice Jollant's research focuses on the cognitive and cerebral bases of vulnerability to suicide.

September 29, 2009
Section : Research

Ashok Malla is an international leader in the development of programs for, and research in, early intervention in psychosis.